Research and Markets: Global Autism Clinical Trials Review 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/h285wm/autism_global) has announced the addition of the "Autism Global Clinical Trials Review, H1, 2014" report to their offering.

Autism Global Clinical Trials Review, H1, 2014 provides data on the Autism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autism.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Espy the commercial landscape of the major Universities / Institutes / Hospitals & Companies

  • Autism Speaks, Inc.
  • Seaside Therapeutics, LLC
  • Forest Laboratories, Inc.
  • Johnson & Johnson
  • Otsuka Holdings Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Coronado Biosciences, Inc.
  • ZonMw
  • Dainippon Sumitomo Pharma Co., Ltd.
  • National Institute of Mental Health
  • Massachusetts General Hospital
  • Tehran University of Medical Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
  • Stanford University
  • The University of Hong Kong
  • University of California, Los Angeles
  • Mount Sinai Hospital
  • University of California, San Francisco

For more information visit http://www.researchandmarkets.com/research/h285wm/autism_global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System